BPC-157
Also Known As: Body Protection Compound 157, BPC157, BPC 157, BPC-157, Pentadecapeptide BPC 157, Stable Gastric Pentadecapeptide, BPC 157 Acetate, Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, Bepecin, PLD-116, PL 14736, PL-10, Cytoprotective Peptide, Gastric Pentadecapeptide, Wolverine Peptide
BPC-157 is a research-grade Synthetic pentadecapeptide derived from human gastric juice protein BPC targeting NO-synthase studied in Healing & Recovery research. It is supplied strictly for in vitro laboratory research use only - not for human or animal consumption, and not FDA-approved.
Evidence Tier: Research Compound - No approved human use; sold for laboratory research only.
A popular research healing peptide with strong rodent data but very limited human evidence.
At A Glance
| Category | Healing & Recovery |
|---|---|
| Compound Class | Synthetic pentadecapeptide derived from human gastric juice protein BPC |
| Molecular Target | NO-synthase, VEGF, FAK/paxillin, EGF receptor, growth hormone receptor; promotes angiogenesis, collagen synthesis, and cytoprotection |
| Molecular Weight | 1419.5 Da |
| Amino Acid Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
| CAS Number | 137525-51-0 |
| Half-Life | ~30 minutes |
| WADA Status | prohibited |
| Evidence Tier | Research Compound |
Mechanism Of Action
It tells your body to build new, healthy blood vessels around the damaged area. More blood means more nutrients, which forces the broken tissue to heal faster.
Studied For
- GI mucosal healing
- Tendon / ligament repair
- Nerve repair
- Anti-inflammatory
- Gut health and integrity
- Leaky gut research
- IBD / Crohn's disease models
- Ulcerative colitis models
- Gastric ulcer healing
- Intestinal anastomosis healing
- Wound healing acceleration
- Muscle tear recovery
- Sports injury recovery
- Joint inflammation reduction
- Bone healing
- Cartilage repair
- Neurological recovery
- Spinal cord injury models
- Peripheral nerve regeneration
- Angiogenesis promotion
- Blood pressure regulation
- Nitric oxide pathway
- Growth hormone receptor upregulation
- Cytoprotection
- Systemic healing
- NSAID-induced gastric damage reversal
- Alcohol-induced gut damage reversal
- Post-surgical healing
- Scar reduction
- Anti-ulcer research
- joint healing
- gut healing
- tendon repair
- ulcer repair
- ligament healing
- muscle tear recovery
- leaky gut
- inflammation reduction
- pain relief
- soft tissue repair
Reported Research Findings
Evidence is overwhelmingly rodent and in vitro: accelerated healing, angiogenesis, and protection against NSAID gastrointestinal damage. Human evidence is very limited; injectable musculoskeletal claims are not established in humans.
Safety And Handling Notes
Rodent toxicology is benign but human adverse-event data are essentially absent. FDA flags immunogenicity, unknown long-term effects, and a theoretical pro-angiogenic tumor-vascularization risk.
Not approved; flagged by the FDA under its 503A bulk-substances compounding-safety review. Named by example under WADA 2026 S0, so it is prohibited at all times in sport. The pro-angiogenic mechanism is a theoretical concern in any malignancy. Research use only.
Regulatory Status
Not FDA-approved; under FDA compounding-safety review (503A bulk-substances evaluation); research chemical. Named by example on the WADA 2026 Prohibited List under S0 (non-approved substances); prohibited at all times as a Specified substance.
Full Reference Detail
Related Research Guides
Maintained By The Pep Nation Lab Research Team. See Our Editorial Standards And Research Methodology For How This Reference Is Sourced And Reviewed.
This Reference Is Provided For In Vitro Laboratory Research Use Only. Not For Human Consumption. See The Full Research Disclaimer.